Literature DB >> 11855887

Papillary serous adenocarcinoma of the ovary diagnosed after malignant pericardial tamponade and embolic stroke.

William E Winter1, Jeffery Seidman, Thomas C Krivak, Susan G Pujari, Charles R Boice, Jay W Carlson.   

Abstract

BACKGROUND: Epithelial carcinomas of the ovary are predominantly an intraperitoneal disease. Reports of epithelial ovarian carcinomas metastatic to the pericardium are rare. CASE: A 43-year-old woman was admitted with symptoms of a pericardial tamponade, as well as an embolic cerebrovascular accident, and transferred to the ICU where a pericardiocentesis was performed. Cytology revealed malignant cells in the pericardial fluid. CT scan of the abdomen and pelvis revealed bilateral pelvic masses. A laparotomy revealed a papillary serous adenocarcinoma of ovarian primary and an infarcted spleen with capsular tumor metastases. The malignant cells in the pericardial fluid were consistent with the ovarian primary.
CONCLUSION: Ovarian cancer metastasis to the heart and pericardium presented an aggressive variant of tumor spread with significant morbidity and subsequent mortality.

Entities:  

Mesh:

Year:  2002        PMID: 11855887     DOI: 10.1006/gyno.2001.6505

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Platinum sensitive carcinoma of ovary relapsed as pericardial effusion with cardiac tamponade.

Authors:  Chinna Babu Dracham; Shipra Gupta; Chandan Krushna Das; Arun Elangovan
Journal:  BMJ Case Rep       Date:  2019-03-22

2.  Fatal cardiac tamponade following cytoreductive surgery for serous carcinoma of the ovary.

Authors:  Emily English; Leah McNally; M Dwight Chen
Journal:  Gynecol Oncol Rep       Date:  2015-07-15

3.  The natural history of pericardial tamponade secondary to recurrent ovarian carcinoma - A case report and review of the literature.

Authors:  I Feferkorn; A Shai; O Gemer; R Auslender; O Lavie
Journal:  Gynecol Oncol Rep       Date:  2014-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.